Baumann Oliver Rolfinsider trades

In SEC Form 4 filings, Baumann Oliver Rolf is listed as Director of Veraxa Biotech AG - Post de-SPAC (VRXA). In the last 90 days, Baumann Oliver Rolf bought $75K of Veraxa Biotech AG - Post de-SPAC (VRXA) on the open market and sold none. The purchase was $75K of Veraxa Biotech AG - Post de-SPAC (VRXA) on Aug 27. Took part in a cluster buy; the latest at Veraxa Biotech AG - Post de-SPAC (VRXA), where 2 insiders bought within 1 day, ending Aug 27.

Companies and roles

Company	Role	Transactions	Last filed
VRXAVeraxa Biotech AG - Post de-SPAC	Director	1	Aug 31

Cluster buys

VRXA: 2 insiders bought $82.7K between Aug 27.

Form 4 historysince 2026-08-31

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
VRXAVeraxa Biotech AG - Post de-SPAC	Aug 27	Aug 31	P	50,000	$1.50	Purchase +$75,000	5,773,618	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.